DaviesKE. The long journey from diagnosis to therapy. Annu Rev Genomics Hum Genet, 2020; 21:1–13. DOI: 10.1146/annurev-genom-112019-083518.
2.
National Academy ofMedicine, National Academy ofSciences, and the RoyalSociety. Heritable Human Genome Editing. Washington, DC: National Academies Press, 2020.
3.
BotsteinD, WhiteRL, SkolnickM, et al.Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am J Hum Genet, 1980; 32:314–331.
National Academies of Science, Engineering, and Medicine. Human Genome Editing: Science, Ethics, and Governance. Washington, DC: National Academies Press, 2017.
8.
ViottiM, VictorAR, GriffinDK, et al.Estimating demand for germline genome editing: an in vitro fertilization clinic perspective. CRISPR J, 2019; 2:304–315. DOI: 10.1089/crispr.2019.0044.
9.
Alanis-LobatoG, ZohrenJ, McCarthyA, et al.Frequent loss-of-heterozygosity in CRISPR-Cas9-edited early human embryos. bioRxiv, 2020June5 [Epub ahead of print]. DOI: 10.1101/2020.06.05.135913.
10.
ZuccaroMV, XuJ, MitchellC, et al.Reading frame restoration at the EYS locus, and allele-specific chromosome removal after Cas9 cleavage in human embryos. bioRxiv, 2020June18 [Epub ahead of print]. DOI: 10.1101/2020.06.17.149237.
11.
LiangD, GutierrezNM, ChenT, et al.Frequent gene conversion in human embryos induced by double strand breaks. bioRxiv, 2020June20 [Epub ahead of print]. DOI: 10.1101/2020.06.19.162214.
12.
LeMieuxJ.The risky business of embryo selection. Gen Eng Biotech News, April1, 2019:20–25.